国际眼科纵览 ›› 2024, Vol. 48 ›› Issue (6): 433-437.doi: 10.3760/ cma.j.issn.1673-5803.2024.06.007

• 综述 • 上一篇    下一篇

Wnt/β-catenin信号通路与近视发病机制的关系

阿地来·艾克拜尔  丁琳   

  1. 新疆医科大学,乌鲁木齐 830054
  • 收稿日期:2023-11-06 出版日期:2024-12-22 发布日期:2024-12-06
  • 通讯作者: 丁琳,Email:Dinglin85600@163.com
  • 基金资助:
    新疆维吾尔自治区自然科学基金面上项目(2022D01C134)

The relationship between Wnt/β-catenin signaling pathway and the pathogenesis of myopia

Adilai·Aikebaier, Ding Lin   

  1. Xinjiang Medical University,Urumqi 830054, China
  • Received:2023-11-06 Online:2024-12-22 Published:2024-12-06
  • Contact: Ding Lin, Email: Dinglin85600@163.com
  • Supported by:
    Xinjiang Uygur Autonomous Region Natural Science Foundation Project (2022D01C134)

摘要: 近视的发病机制涉及复杂的视网膜-脉络膜-巩膜调节过程,其中Wnt/β-catenin通路作为重要的信号通路在近视的发展中起关键作用。Wnt/β-catenin通路的激活与近视的严重程度呈正相关,抑制该通路可能有助于延缓近视进展。近视患者血液中Wnt/β-catenin通路抑制剂DKK-1(Dickkopf-1)表达水平明显偏低,而DKK-1的补充则有可能减缓眼球轴向生长和近视漂移,这为基于Wnt/β-catenin通路的治疗策略开辟了新的研究方向。 (国际眼科纵览,2024, 48:433-437

关键词: Wnt/β-catenin通路, 近视

Abstract: The etiology of myopia involves a complex regulatory process of the retina-choroid-sclera axis, wherein the Wnt/β-catenin pathway plays a pivotal role as a significant signaling pathway in myopia development. Studies indicate that activation of the Wnt/β-catenin pathway correlates positively with the severity of myopia, and inhibiting this pathway may potentially slow the progression of myopia. Moreover, individuals with myopia exhibit significantly reduced levels of DKK-1 (Dickkopf-1) in their blood, and supplementation of DKK-1 may mitigate axial elongation of the eye and progression of myopia. These findings pave the way for novel research directions in therapeutic strategies based on the Wnt/β-catenin pathway.(Int Rev Ophthalmol, 2024, 48:  433-437)

Key words: Wnt/β-catenin signaling pathways, myopia